| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 221.334 | 116.931 | 312.263 | 274.467 | 31.282 | 0 | 0 | 0 |
| Total Income - EUR | - | 925 | 225.450 | 119.880 | 321.432 | 285.075 | 38.232 | 7.299 | 6.220 | 732 |
| Total Expenses - EUR | - | 1.326 | 58.375 | 28.909 | 65.824 | 105.375 | 46.266 | 8.625 | 5.812 | 2.053 |
| Gross Profit/Loss - EUR | - | -402 | 167.075 | 90.971 | 255.608 | 179.700 | -8.034 | -1.326 | 408 | -1.321 |
| Net Profit/Loss - EUR | - | -420 | 160.434 | 87.463 | 247.273 | 173.438 | -8.782 | -1.326 | 346 | -1.321 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Nci Biomedical Solution Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 86 | 0 | 0 | 0 | 162.917 | 137.825 | 118.502 | 118.143 | 117.482 |
| Current Assets | - | 124.983 | 170.804 | 238.766 | 421.338 | 449.430 | 406.968 | 395.680 | 384.075 | 545.139 |
| Inventories | - | 24.110 | 5.589 | 16.790 | 1.142 | 64 | 111.804 | 112.151 | 111.811 | 111.186 |
| Receivables | - | 67.598 | 126.849 | 88.851 | 292.912 | 370.800 | 219.520 | 161.092 | 138.386 | 285.993 |
| Cash | - | 33.275 | 38.366 | 133.126 | 127.283 | 78.565 | 75.643 | 122.436 | 133.877 | 147.960 |
| Shareholders Funds | - | -376 | 160.065 | 218.189 | 417.499 | 583.022 | 540.271 | 530.162 | 518.133 | 494.250 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 125.446 | 10.740 | 20.577 | 3.839 | 29.325 | 4.522 | 3.770 | 3.775 | 187.951 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Nci Biomedical Solution Srl